batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Erasca heads for phase 3 at last 4 April 2024 BioNTech and DualityBio branch out 4 April 2024 Carisma switches cells 3 April 2024 Ipsen buys into ROR1 after Boehringer’s exit 2 April 2024 Bristol bids to outdo Amgen in KRAS 2 April 2024 The first-quarter curtain falls on Pieris and Gamida 28 March 2024 Novocure’s brain mets win comes with caveats 28 March 2024 Syndax menin inhibitor gets its big day 27 March 2024 Load More